New hope for stubborn weight after surgery: drug trial offers second chance
NCT ID NCT06162715
Summary
This pilot study is testing if the medication Tirzepatide can help people who still have significant obesity (BMI over 30) one year after having gastric bypass surgery. It will compare the weight loss and body composition changes in 30 people taking the drug for 24 weeks to those receiving standard post-surgery care. A key goal is to see how often and how severely patients experience stomach-related side effects from the medication after this specific surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37209, United States
Conditions
Explore the condition pages connected to this study.